Xeomin (incobotulinumtoxinA)

incobotulinumtoxinA · Merz Pharma

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Xeomin (incobotulinumtoxinA), covering 2015-12-31 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study [NA]